Faeth believes that the use of metabolism and precision nutrition will join surgery, radiotherapy, small molecules (e.g. chemotherapy, targeted therapies), and biologics (e.g. immunotherapy, antibodies) as a foundational treatment for cancer. Faeth is a data-driven, evidence-based company with a deep understanding of the way that dietary nutrients influence tumor growth and cancer treatment. The team is fully focused on matching specific diets with tumor genotypes and treatment regimens to improve the outcomes of cancer therapy.